strategy

FIT-II (everis’ investment fund) looks for investment opportunities relying on committed teams and innovative technology. In this new investment phase, FIT-II has reinforced its commitment with innovation through the development of three different strategic lines, each of them with its own portfolio:

venture capital

“Venture Capital” (VC) focuses on standard, high potential deals ranging from IT (included Digital Business) to Manufacturing, Biotechnology / Pharma and Energy, as long as the company has already developed a product or it is preclinical phase in case of Bio/Pharma leads.

corporate venturing

On the other hand, “Corporate Venturing” pursues similar deals but the involvement of everis’ business lines is a prerequisite.

company building

Finally, “Company Building” looks for disruptive technology based start-ups, in very early stage, and a high potential growth in the short / medium term. The main objective is to build, fund, and scale new businesses in partnership with corporates and entrepreneurs.

Contact Us

×
Cookies are important for the proper functioning of this site. To improve this experience, we use both our own and third-party cookies in order to allow the user to browse in this site and to use its services as well as to remember the user’s preferences and collect data to optimize the functionality of the site. Please Click on OK and continue to accept the cookies and go directly to the site. For more information on cookies please refer to our legal noticeOK, I agree